Friday 7 November 2014

Dr Reddy's, Endo get FDA approval to launch generic Valcyte

MUMBAI (Reuters) - The U.S. Food and Drug Administration (FDA) said it has granted final approval to Indian drugmaker Dr Reddy's Laboratories Ltd and U.S. firm Endo International Plc to make cheaper copies of Roche Holding AG's antiviral Valcyte. The move comes after Ranbaxy Laboratories Ltd said on Thursday that FDA had stripped the company of its tentative approval to launch the first copy of the drug due to quality control issues at its manufacturing plants. ... via Health News Headlines - Yahoo News Read More Here..

No comments:

Post a Comment